GlassScriptPhysician profile
Aaron W Tungate
NPI 1518911106
$585.21
in general payments reported to CMS, 2019-2025
11 companies · $22.24 in 2025
The $22.24 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.55 · 2022: $199 · 2023: $275 · 2024: $13.68 · 2025: $22.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $311.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $115.87 | 2022-2023 | Camzyos, Eliquis |
| Pfizer INC. | $106.28 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $76.26 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.76 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $57.57 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.67 | 2021-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $41.87 | 2021-2022 | |
| Ge Healthcare | $22.24 | 2025 | |
| Sanofi-Aventis U.S. LLC | $17.76 | 2023 | |
| Heartflow, INC. | $16.23 | 2023 | Ffrct |
| Amgen INC. | $15.70 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Tungate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.